Prostacyclin formation elicited by endothelin-1 in rat aorta is mediated via phospholipase D activation and not phospholipase C or A2

Circulation Research

Volumn 79, Issue 2, 1996, Pages 271-276

  Wright, Harold M ^a   Malik, Kafait U ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

aorta; endothelin; phospholipases; prostaglandins

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1,6 HEXAMETHYLENEDICARBAMIC ACID BIS(CYCLOHEXANONE OXIME) ESTER; 6 OXOPROSTAGLANDIN F1 ALPHA; ALCOHOL; CERAMIDE; ENDOTHELIN 1; INOSITOL PHOSPHATE; NORADRENALIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PHOSPHOLIPASE INHIBITOR; PROPRANOLOL; PROSTACYCLIN; PROTEIN KINASE C INHIBITOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; VASCULAR RING;

EID: 0030035301     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.2.271     Document Type: Article

References (32)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Douglas SA, Meek TD, Ohlstein EH. Novel receptor antagonists welcome a new era in endothelin biology. Trends Pharmacol Sci. 1994;15:313-316.
3. A receptor via influx of calcium and is independent of protein kinase C. Hypertension. 1995;26:1035-1040.
4. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976;263:663-665.
5. De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988;85:9797-9800.
6. 2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem. 1994;269:11938-11944.
7. 2 and their membrane substrates. Trends Cardiovasc Med. 1992;2:115-121.
8. 2. J Biol Chem. 1994;269:13057-13060.
9. Balsinde J, Diez E, Mollinedo F. Arachidonic acid release from diacylglycerol in human neutrophils. J Biol Chem. 1991 ;256:15638-15643.
10. Lapetina EG, Billah MM, Cuatrecasas P. The initial action of thrombin on platelets. J Biol Chem. 1981;256:5037-5040.
11. Brindley DN. Intracellular translocation of phosphatidate phosphohydrolase and its possible role in the control of glycerolipid synthesis. Prog Lipid Res. 1984;23:115-133.
12. 1α from aldosterone-salt hypertensive rats. J Vasc Res. 1992;29:256-263.
13. 1 cell. J Biol Chem. 1989;264:8520-8528.
14. Smith RJ, Sam LM, Justen JM, Bundy GL, Bala GA, Bleasdale JE. Receptor-coupled signal transaction in human polymorphonuclear neutrophiis: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J Pharmacol Exp Ther. 1990;253:688-697.
15. Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fitzpatrick FA, Smith RJ, Bunting S. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophiis. J Pharmacol Exp Ther. 1990;255:756-768.
16. Billah MM, Eckel S, Mullmann TJ, Egan RW, Siegel MI. Phosphatidylcholine hydrolysis by phospholipase D determines phosphatidate and diglyceride levels in chemotactic peptide-stimulated human neutrophiis. J Biol Chem. 1989;264:17069-17077.
17. 2 and diglyceride lipase. J Biol Chem. 1982;257:14006-14010.
18. Gomez-Munoz A, Waggoner DW, O'Brien L, Brindley DN. Interaction of ceramides, sphingosine, sphingosine-1-phosphate in regulating DNA synthesis and phospholipase D activity. J Biol Chem. 1995;270;26318-26325.
19. Venable ME, Blobe GC, Obeid LM. Identification of a defect in the phospholipase D/diacylglycerol pathway in cellular senescence. J Biol Chem. 1994;269:26040-26044.
20. Bonser RW, Thompson NT, Randall RW, Garland LG. Phospholipase D activation is functionally linked to Superoxide generation in the human neutrophil. Biochem J. 1989;264:617-620.
21. 2 and activation in mouse peritoneal macrophages. J Biol Chem. 1995;270:20439-20446.
22. Ohlstein EH, Horohonich S, Hay DWP. Cellular mechanisms of endothelin in rabbit aorta. J Pharmacol Exp Ther. 1989;250:548-555.
23. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kerilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266:15771-15781.
24. Liu Y, Geisbuhler B, Jones AW. Activation of multiple mechanisms including phospholipase D by endothelin-1 in rat aorta. Am J Physiol. 1992;262:941-949.
25. 1-Adrenergic receptor-mediated activation of phospholipase D in rat cerebral cortex. J Biol Chem. 1992;267:3679-3685.
26. Shaffer JE, Malik KU. Enhancement of prostaglandin output during activation of beta-1 adrenoceptors in the isolated rabbit heart. J Pharmacol Exp Ther. 1982;223:729-735.
27. 2 from the human monocytic cell line U937. Proc Natl Acad Sci U S A. 1990;87:7708-7712.
28. Liu J, Mathias S, Yang Z, Kolesnick RN. Renaturation and tumor necrosis factor-α stimulation of a 97-kDa ceramide-activated protein kinase. J Biol Chem. 1994;269:3047-3052.
29. Hannun YA. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem. 1994;269:3125-3128.
30. 2+ mobilization in smooth muscle cells by protein kinase C. Am J Physiol. 1994;266:C1560-C1567.
31. Geny B, Cockcroft S. Synergistic activation of phospholipase D by protein kinase C- and G-protein-mediated pathway in streptolysin O-permeabilized HL60 cells. Biochem J. 1992;284:531-538.
32. 2+, protein kinase C, and protein kinase A in hormonal stimulation of phospholipase D in rat hepatocytes. J Biol Chem. 1994;269:849-859.